TipRanks
Stoke Therapeutics Inc (DE:0GT)
FRANKFURT:0GT
Germany Market
0GT
Stoke Therapeutics
RESEARCH TOOLSreports

Stoke Therapeutics (0GT) Income Statement

0 Followers

Stoke Therapeutics Income Statement

Last quarter (Q2 2026), Stoke Therapeutics's total revenue was $9.32M, a decrease of -32.51% from the same quarter last year. In Q2, Stoke Therapeutics's net income was $-61.62M. See Stoke Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Gross Profit
$ 184.42M$ 36.55M$ 8.78M$ 12.40M$ 0.00
Operating Expenses
$ 205.01M$ 137.93M$ 123.55M$ 116.76M$ 86.06M
Depreciation and Amortization
$ 1.77M$ 2.18M$ 2.47M$ 1.55M$ 974.00K
EBITDA
$ -5.12M$ -86.80M$ -102.23M$ -99.52M$ -84.83M
Operating Income
$ -20.59M$ -101.37M$ -114.77M$ -104.36M$ -86.06M
Other Income/Expenses
$ 13.71M$ 12.39M$ 10.07M$ 3.29M$ 260.00K
Pretax Income
$ -6.88M$ -88.98M$ -104.70M$ -101.07M$ -85.81M
Net Income
$ -6.88M$ -88.98M$ -104.70M$ -101.07M$ -85.81M
Per Share Metrics
Basic EPS
$ -0.12$ -1.65$ -2.38$ -2.60$ -2.34
Diluted EPS
$ -0.12$ -1.65$ -2.38$ -2.60$ -2.34
Weighted Average Shares Outstanding
 59.22M 54.01M 43.99M 38.90M 36.74M
Weighted Average Shares Outstanding (Diluted)
 59.22M 54.01M 43.99M 38.90M 36.74M
Currency in USD

Stoke Therapeutics Earnings and Revenue History